socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150

Pricing Thousand Oaks Startup Design 150

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. Ceres said it now expects its IPO to price at between $21.00 and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

JANUARY 30, 2012

Thousand Oaks-based Ceres , which develops specialized seeds for the biofuels industry, is planning to hit the market on February 9th, according to the NASDAQ IPO calendar. Ceres recently estimated its IPO pricing at between $21.00 If successful, the offering will raise $132.25M for the company. and $23.00

Thousand Oaks 153

Thousand Oaks Marketing Southern California Pricing 153

socalTECH

FEBRUARY 23, 2012

Thousand Oaks-based Ceres , the biotechnology firm developing specialized seed stocks for the biofuels industry, rose in its IPO on Wednesday, closing at $14.80 The firm priced its IPO on Tuesday evening at $13.00 per share, pricing lower than expected after a delay in its IPO.

Thousand Oaks 145

Thousand Oaks Southern California Pricing Activity 145

socalTECH

JULY 22, 2010

Southern California appears to be on a IPO roll this month, with the pricing of Monrovia-based Green Dot 's IPO last night and expected trading today, following the successful IPO of Beverly Hills-based RealD last Friday.

Southern California 140

Southern California Westlake Village Woodland Hills Beverly Hills 140

socalTECH

MAY 20, 2010

per share, after pricing below its initial offering range on Wednesday evening, and had traded as high as $15.26 The firm's stock was up in its debut despite a down market for the day, with the NASDAQ down -4.11 The firm's stock was up in its debut despite a down market for the day, with the NASDAQ down -4.11 during the day.

ReachLocal 157

ReachLocal Woodland Hills Thousand Oaks NewEgg 157

Xconomy

JUNE 10, 2016

The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. As the conference wrapped up, a Morgan Stanley analyst noted that Pfizer the previous week had raised its drug prices nine percent, continuing a regular pattern of price increases.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67